Nearly 15 per cent of CSL’s global workforce will be reduced in the biggest shake-up of the company in decades aimed at “simplifying the business”. CSL employs about 30,000 staff globally. Its share ...
CSL will outlay $1.5bn over the next five years in the US to grow its footprint of plasma therapy production, the latest pharma company to pour money into the country amid tariff threats.
Australia's largest pharmaceutical company will cut 3000 jobs globally, with $20bn wiped from the company’s market value. Nearly 15 per cent of CSL’s global workforce will be reduced in the biggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback